CEBPG regulates ERCC5/XPG expression in human bronchial epithelial cells and this regulation is modified by E2F1/YY1 interactions

被引:34
作者
Crawford, E. L.
Blomquist, T.
Mullins, D. N.
Yoon, Y.
Hernandez, D. R.
Al-Bagdhadi, M.
Ruiz, J.
Hammersley, J.
Willey, J. C. [1 ]
机构
[1] Univ Toledo, Dept Med, Toledo, OH 43614 USA
[2] Univ Toledo, Dept Pathol, Toledo, OH 43614 USA
关键词
D O I
10.1093/carcin/bgm214
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Marked inter-individual variation in lung cancer risk cannot be accounted for solely by cigarette smoke and other environmental exposures. Evidence suggests that variation in bronchial epithelial cell expression of key DNA repair genes plays a role. Variation in these genes correlates with variation in expression of CEBPG and E2F1 transcription factors. Here, we investigated the mechanistic basis for correlation of the DNA repair gene ERCC5 (previously known as XPG) with CEBPG and E2F1. CEBPG expression vector transfected into H23 or H460 cell lines up-regulated endogenous ERCC5 and also luciferase from a reporter construct containing 589 bp of ERCC5 5' regulatory region. A recognition site for CEBPG and a region containing sites for YY1 on the sense strand and E2F1 on the anti-sense strand participated in CEBPG up-regulation of ERCC5. CEBPG, E2F1 and YY1 binding to their respective sites were confirmed by electrophoretic mobility shift assay. Thus, we conclude that CEBPG regulates ERCC5 expression and this regulation is modified by E2F1/YY1 interactions. Several polymorphisms have been identified in these regions and, based on the data presented here, it is reasonable to hypothesize that they may contribute to risk for bronchogenic carcinoma.
引用
收藏
页码:2552 / 2559
页数:8
相关论文
共 71 条
[11]   A RAPID AND VERSATILE METHOD TO SYNTHESIZE INTERNAL STANDARDS FOR COMPETITIVE PCR [J].
CELI, FS ;
ZENILMAN, ME ;
SHULDINER, AR .
NUCLEIC ACIDS RESEARCH, 1993, 21 (04) :1047-1047
[12]  
Cheng L, 1998, CANCER EPIDEM BIOMAR, V7, P465
[13]   In vitro assays fall to predict in vivo effects of regulatory polymorphisms [J].
Cirulli, Elizabeth T. ;
Goldstein, David B. .
HUMAN MOLECULAR GENETICS, 2007, 16 (16) :1931-1939
[14]   IG/EBP (C/EBP-GAMMA) IS A TRANSDOMINANT NEGATIVE INHIBITOR OF C/EBP FAMILY TRANSCRIPTIONAL ACTIVATORS [J].
COOPER, C ;
HENDERSON, A ;
ARTANDI, S ;
AVITAHL, N ;
CALAME, K .
NUCLEIC ACIDS RESEARCH, 1995, 23 (21) :4371-4377
[15]   C/EBPγ has a stimulatory role on the IL-6 and IL-8 promoters [J].
Gao, HW ;
Parkin, S ;
Johnson, PF ;
Schwartz, RC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (41) :38827-38837
[16]   Genetic variation in the nucleoticle excision repair pathway and bladder cancer risk [J].
García-Closas, M ;
Malats, N ;
Real, FX ;
Welch, R ;
Kogevinas, M ;
Chatterjee, N ;
Pfeiffer, R ;
Silverman, D ;
Dosemeci, M ;
Tardón, A ;
Serra, C ;
Carrato, A ;
García-Closas, R ;
Castaño-Vinyals, G ;
Chanock, S ;
Yeager, M ;
Rothman, N .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (03) :536-542
[17]  
Greenwald P, 1996, J CELL BIOCHEM, P29
[18]  
Grossman L, 1999, NATO ADV SCI I A-LIF, V302, P149
[19]   PATTERNS OF ABSOLUTE RISK OF LUNG-CANCER MORTALITY IN FORMER SMOKERS [J].
HALPERN, MT ;
GILLESPIE, BW ;
WARNER, KE .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (06) :457-464
[20]   C/EBPBeta and Elk-1 synergistically transactivate the c-fos serum response element [J].
Hanlon M. ;
Bundy L.M. ;
Sealy L. .
BMC Cell Biology, 1 (1)